166 related articles for article (PubMed ID: 38106558)
21. EGFR inhibitors as adjuvant therapy for resected non-small cell lung cancer harboring EGFR mutations.
Tang W; Li X; Xie X; Sun X; Liu J; Zhang J; Wang C; Yu J; Xie P
Lung Cancer; 2019 Oct; 136():6-14. PubMed ID: 31421260
[TBL] [Abstract][Full Text] [Related]
22. Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(24):1-48. PubMed ID: 23074402
[TBL] [Abstract][Full Text] [Related]
23. A prognostic model for predicting progression-free survival in patients with advanced non-small cell lung cancer after image-guided microwave ablation plus chemotherapy.
Kong F; Yang H; Wang Q; Wei Z; Ye X
Eur Radiol; 2023 Nov; 33(11):7438-7449. PubMed ID: 37318606
[TBL] [Abstract][Full Text] [Related]
24. Plasma D-Dimer Level Correlates with Age, Metastasis, Recurrence, Tumor-Node-Metastasis Classification (TNM), and Treatment of Non-Small-Cell Lung Cancer (NSCLC) Patients.
Guo J; Gao Y; Gong Z; Dong P; Mao Y; Li F; Rong J; Zhang J; Zhou Y; Feng H; Guo H; Gu L; An M; Wen K; Zhang J
Biomed Res Int; 2021; 2021():9623571. PubMed ID: 34712737
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a prediction model using molecular marker for long-term survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy.
Yang Y; Zhang T; Zhou Z; Liang J; Chen D; Feng Q; Xiao Z; Hui Z; Lv J; Deng L; Wang X; Wang W; Wang J; Liu W; Zhai Y; Wang J; Bi N; Wang L
Thorac Cancer; 2022 Feb; 13(3):296-307. PubMed ID: 34927371
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of prognosis and influencing factors of No. 253 lymph node metastasis in descending colon, sigmoid colon, and rectal cancer: a multicenter study].
Zhao FQ; Zhou L; Du XH; Wu AW; Yang H; Xu L; Liu XZ; Hu SD; Xiao Y; Liu Q
Zhonghua Wai Ke Za Zhi; 2023 Sep; 61(9):760-767. PubMed ID: 37491168
[No Abstract] [Full Text] [Related]
27. Evaluation of disease-free survival as a predictor of overall survival and assessment of real-world burden of disease recurrence in resected early-stage non-small cell lung cancer.
West H; Hu X; Zhang S; Song Y; Chirovsky D; Gao C; Lerner A; Jiang A; Signorovitch J; Samkari A
J Manag Care Spec Pharm; 2023 Jul; 29(7):749-757. PubMed ID: 37404067
[No Abstract] [Full Text] [Related]
28. Construction and validation of prognostic nomograms for elderly patients with metastatic non-small cell lung cancer.
Sun H; Liu M; Yang X; Ren Y; Dai H; Wang C
Clin Respir J; 2022 May; 16(5):380-393. PubMed ID: 35514033
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of a prognostic nomogram for early stage non-small cell lung cancer: a study based on the SEER database and a Chinese cohort.
Zhou L; Zhang Y; Chen W; Niu N; Zhao J; Qi W; Xu Y
BMC Cancer; 2022 Sep; 22(1):980. PubMed ID: 36104656
[TBL] [Abstract][Full Text] [Related]
30. Development and External Validation of a Nomogram for Predicting Cancer-Specific Survival of Non-Small Cell Lung Cancer Patients With Ipsilateral Pleural Dissemination.
Wang Z; Li H; Liu T; Sun Z; Yang F; Jiang G
Front Oncol; 2021; 11():645486. PubMed ID: 34350108
[TBL] [Abstract][Full Text] [Related]
31. Stage I synchronous multiple primary non-small cell lung cancer: CT findings and the effect of TNM staging with the 7th and 8th editions on prognosis.
Li J; Yang X; Xia T; Guan Y; Zhong N
J Thorac Dis; 2017 Dec; 9(12):5335-5344. PubMed ID: 29312743
[TBL] [Abstract][Full Text] [Related]
32. Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients.
Wang J; Wu N; Lv C; Yan S; Yang Y
J Cancer Res Clin Oncol; 2019 Feb; 145(2):463-469. PubMed ID: 30474757
[TBL] [Abstract][Full Text] [Related]
33. A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies.
Kratz JR; He J; Van Den Eeden SK; Zhu ZH; Gao W; Pham PT; Mulvihill MS; Ziaei F; Zhang H; Su B; Zhi X; Quesenberry CP; Habel LA; Deng Q; Wang Z; Zhou J; Li H; Huang MC; Yeh CC; Segal MR; Ray MR; Jones KD; Raz DJ; Xu Z; Jahan TM; Berryman D; He B; Mann MJ; Jablons DM
Lancet; 2012 Mar; 379(9818):823-32. PubMed ID: 22285053
[TBL] [Abstract][Full Text] [Related]
34. Significantly different immunological score in lung adenocarcinoma and squamous cell carcinoma and a proposal for a new immune staging system.
Zeng Z; Yang F; Wang Y; Zhao H; Wei F; Zhang P; Zhang X; Ren X
Oncoimmunology; 2020; 9(1):1828538. PubMed ID: 33101777
[TBL] [Abstract][Full Text] [Related]
35. Radiographical assessment of tumour stroma and treatment outcomes using deep learning: a retrospective, multicohort study.
Jiang Y; Liang X; Han Z; Wang W; Xi S; Li T; Chen C; Yuan Q; Li N; Yu J; Xie Y; Xu Y; Zhou Z; Poultsides GA; Li G; Li R
Lancet Digit Health; 2021 Jun; 3(6):e371-e382. PubMed ID: 34045003
[TBL] [Abstract][Full Text] [Related]
36. Computed tomography (CT) predicts accurately the pathologic tumour size in stage I non-small-cell lung cancer (NSCLC).
Cedrés S; Quispe I; Martínez P; Longo M; Rodríguez E; Serrano C; Muñoz E; Pallisa E; Felip E
Clin Transl Oncol; 2010 Dec; 12(12):829-35. PubMed ID: 21156414
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J
Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165
[TBL] [Abstract][Full Text] [Related]
38. The value of CRP-albumin-lymphocyte index (CALLY index) as a prognostic biomarker in patients with non-small cell lung cancer.
Liu XY; Zhang X; Zhang Q; Ruan GT; Liu T; Xie HL; Ge YZ; Song MM; Deng L; Shi HP
Support Care Cancer; 2023 Aug; 31(9):533. PubMed ID: 37610445
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of total lesion glycolysis and metabolic active tumor volume in non-small cell lung cancer.
Vanhove K; Mesotten L; Heylen M; Derwael R; Louis E; Adriaensens P; Thomeer M; Boellaard R
Cancer Treat Res Commun; 2018; 15():7-12. PubMed ID: 30207286
[TBL] [Abstract][Full Text] [Related]
40. A hypothesized TNM staging system based on the number and location of positive lymph nodes may better reflect the prognosis for patients with NSCLC.
Shang X; Liu J; Li Z; Lin J; Wang H
BMC Cancer; 2019 Jun; 19(1):591. PubMed ID: 31208403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
